How would I verify whether custom adapters have annealed properly? I get odd results when trying to quantify using QuBit, PicoGreen or TapeStation. Since the majority of the adapter is still single stranded, is there even a way to tell?
-
-
As you have done, Qubit or PicoGreen is the easiest and very informative. With increasing annealing efficiency you should see increasing value in concentration of dsDNA. I regularly use this method as a QC for adapters with full length or partial length complimentary regions to ensure batch to batch consistency. Obviously, adapters with short complimentary region will have lower florescence, but it is sensitive enough to discriminate between annealed and non-annealed oligos. One also can calculate theoretical expected concentration for partially or completely complimentary oligos for any given annealing efficiency. -
You could also try denaturing them to see how much that reduces their fluorescence with a dsDNA-specific dye.Comment
-
What kind of values have you seen with say a full TruSeq adapter?Originally posted by nucacidhunter View Post
That's a good idea. I tried something similar by comparing the annealed(?) product versus an equimolar mixture of unannealed oligos. With a Qubit dsDNA BR kit it did not seem to make a difference - they all seemed to generate a similar value. With PicoGreen I believe I received roughly double the concentration. However, even the individual ssDNA oligos generated a value.Originally posted by jwfoley View PostComment
-
I have not done exact math. Using 10 uM (each) 40 base long adapter oligos with full complimentary bases across oligos I get around 70 ng/ul with PicoGreen and for 10 uM 30 base long oligos with 14 complimentary nucleotides 30 ng/ul.What kind of values have you seen with say a full TruSeq adapter?Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment